CStone Pharmaceuticals Sustainability Reports

CStone Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative immuno-oncology therapies and precision medicines. The company develops targeted therapeutics, monoclonal antibodies, and combination treatments for various cancer indications.

Sector: Manufacturing

Country: China

Exchange: Hong Kong Stock Exchange

LEI: 300300095A57F80T2461

FIGI: BBG00N9XPMB9

16 reports from 2018 to 2025

• CStone Pharmaceuticals 2025 Annual Report
• CStone Pharmaceuticals 2025 Environmental, Social and Governance Report
• CStone Pharmaceuticals 2024 Annual Report
• CStone Pharmaceuticals 2024 Environmental, Social and Governance Report
• CStone Pharmaceuticals 2023 Annual Report